Your browser doesn't support javascript.
loading
TiO2 nanoparticles abrogate the protective effect of the Crohn's disease-associated variation within the PTPN22 gene locus.
Schwarzfischer, Marlene; Niechcial, Anna; Handler, Kristina; Morsy, Yasser; Wawrzyniak, Marcin; Laimbacher, Andrea S; Atrott, Kirstin; Manzini, Roberto; Baebler, Katharina; Hering, Larissa; Katkeviciute, Egle; Häfliger, Janine; Lang, Silvia; Keller, Maja E; Woodtli, Jérôme; Eisenbeiss, Lisa; Kraemer, Thomas; Schraner, Elisabeth M; Wiesendanger, Mahesa; Zeissig, Sebastian; Rogler, Gerhard; Moor, Andreas E; Scharl, Michael; Spalinger, Marianne R.
Affiliation
  • Schwarzfischer M; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Niechcial A; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Handler K; Department of Biosystems Science and Engineering, ETH Zurich, Zurich, Switzerland.
  • Morsy Y; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Wawrzyniak M; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Laimbacher AS; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Atrott K; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Manzini R; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Baebler K; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Hering L; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Katkeviciute E; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Häfliger J; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Lang S; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Keller ME; Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland.
  • Woodtli J; Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland.
  • Eisenbeiss L; Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland.
  • Kraemer T; Department of Forensic Pharmacology and Toxicology, Zurich Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland.
  • Schraner EM; Institutes of Veterinary Anatomy and Virology, University of Zurich, Zurich, Switzerland.
  • Wiesendanger M; Institutes of Veterinary Anatomy and Virology, University of Zurich, Zurich, Switzerland.
  • Zeissig S; Center for Regenerative Therapies Dresden (CRTD), Technische Universität (TU) Dresden, and Department of Medicine I, University Medical Center Dresden, Dresden, Germany.
  • Rogler G; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Moor AE; Department of Biosystems Science and Engineering, ETH Zurich, Zurich, Switzerland.
  • Scharl M; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland michael.scharl@usz.ch.
  • Spalinger MR; Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Gut ; 72(6): 1101-1114, 2023 06.
Article in En | MEDLINE | ID: mdl-36191962

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Crohn Disease / Colitis / Nanoparticles Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Gut Year: 2023 Type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Crohn Disease / Colitis / Nanoparticles Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Gut Year: 2023 Type: Article Affiliation country: Switzerland